<DOC>
	<DOCNO>NCT02496364</DOCNO>
	<brief_summary>Lumbar degenerative disease surgery entails high blood loss , require often blood transfusion . The cost risk involve use allogeneic blood motivate research method reduce operative bleeding patient . One method use anti-fibrinolytic drug , among tranexamic acid .</brief_summary>
	<brief_title>Evaluation Topical Intravenous Tranexamic Acid Surgical Treatment Lumbar Degenerative Disease</brief_title>
	<detailed_description>This study enroll 144 middle-aged age patient undergo Posterior Lumbar Interbody Fusion ( PLIF ) diagnosis Lumbar Degenerative Disease . The primary aim determine topical application tranexamic acid effective intravenous infusion decrease blood loss blood transfusion perioperatively middle-aged aged patient present PLIF surgery .</detailed_description>
	<mesh_term>Scoliosis</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Tranexamic Acid</mesh_term>
	<criteria>Diagnosis lumbar degenerative disease segmental instability and/or lumbar stenosis ; Having body weight less 100kg Indicative Posterior lumbar interbody fusion three level less Diagnosis renal hepatic insufficiency History bleeding disorder thromboembolism History coronary heart disease History peripheral vascular disease Commonly use anticoagulant drug Contraindication use tranexamic acid Surgery history spine Religious restriction blood transfusion</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>Tranexamic Acid</keyword>
	<keyword>Scoliosis</keyword>
	<keyword>bleed control</keyword>
</DOC>